Paraganglioma

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS approval · 2019-01-30
Clinical Trial Update: Expanded Access Program of Ultratrace Iobenguane I131 for Malignant Relapsed/Refractory Pheochromocytoma/Paraganglioma
Marketing approval for Ultratrace iobenguane I-131 has been granted for malignant relapsed/refractory pheochromocytoma and paraganglioma, pe…